AGHeadlines: Clinical Updates and NHS Developments in Women’s Health – Winter 2025/26
- Hannah Hunt
- Jan 30
- 2 min read
Welcome to the latest edition of AGHeadlines, providing you with insight every quarter on the latest technologies and tools in women's health helping clinicians deliver exceptional care for women in the UK.
In This Edition
WEQAS Launches External Quality Assessment Scheme for AmniSure®
From 17 December 2025, the Wales External Quality Assessment Scheme (WEQAS) has launched a dedicated External Quality Assessment (EQA) scheme for the AmniSure® test, used in the detection of rupture of membranes. This represents a significant step forward in clinical governance and quality assurance.
WEQAS is a nationally recognised, independent EQA provider, and the introduction of a scheme specific to AmniSure® reflects the test’s:
Established use within UK maternity services
Clinical relevance in the assessment of suspected rupture of membranes
Suitability for formal external quality monitoring
Hospitals and NHS trusts can enrol directly with WEQAS. For teams reviewing local testing pathways or governance frameworks, this development provides additional reassurance and standardisation for AmniSure® use in clinical practice.
AGHealth can also support discussions around implementation and enrolment via local account managers. Contact AGHealth for support with enrolment here.
NHS Pilots Underway for the WID-easy® Test
This month, AGHealth has launched additional NHS pilots across selected trusts in the UK of the simple and accurate WID-easy test for endometrial cancer.
These pilots are supporting clinical teams to improve triage for women referred via the USC pathway with abnormal uterine bleeding, while also helping services meet their 28-day Faster Diagnosis Standard targets.
We look forward to welcoming more pilot sites in the months ahead.
Upcoming Events
Conferences
AGHealth will be attending:
BSGE ACN Conference 26–27 February 2026 | Birmingham
Webinars and Virtual Training
Healthcare professionals are invited to register for upcoming clinical training sessions:
DILAPAN-S® Virtual Training 30 January 2026 | 12:00 (UK time)
AmniSure® Virtual Training 13 February 2026 | 12:00 (UK time)
DILAPAN-S® Virtual Training 27 March 2026 | 12:00 (UK time)
These sessions are suitable for clinicians seeking refresher training or product-specific education. Register for any of our free training events here.
Quarterly Special Offers – Limited Time Only
Obstetrics: Buy 10, Get 1 Free
Available until 1 March 2026
For a limited time, receive 1 free box for every 10 boxes purchased across the following obstetric products:
DILAPAN-S®
AmniSure®
PartoSure®
Quote “FREEBOX” on your purchase order to claim.
Neonatal Care: Save 40% on Neotech
Available until 25 February 2026
Save 40% across the Neotech range, supporting neonatal care with significant cost savings.
Please note: NeoBar and NeoGrip are excluded from this offer.
Quote “MC40” on your purchase order to claim.
Supporting Evidence-Based Women’s Healthcare
AGHeadlines is designed to support UK women’s healthcare professionals with timely updates on diagnostics, governance initiatives, clinical education, and service improvement. By staying informed of developments across obstetrics, gynaecology, and neonatal care, clinical teams can continue to deliver safe, high-quality, and evidence-based care.
For further information on any of the updates above, AGHealth can provide product, training, or pilot support as required.
